site stats

Houston brain trauma patients will test new treatment

SOURCE

Patients taken to Houston’s two renowned ERs with severe brain trauma will have an additional hole drilled in their skulls as part of a national trial to evaluate the potential benefit of treatment based on oxygen levels.

It’s used by some doctors and not others,” said Dr. Elizabeth Jones, an emergency medicine doctor at McGovern Medical School at UTHealth and leader of the trial’s south Texas sites. “But because a trial hasn’t been done, there’s no strong evidence that it benefits patients, that it translates into better outcomes.”

The south Texas sites are the trauma centers at Memorial Hermann Hospital and Ben Taub Hospital in the Texas Medical Center and at UT Health Science Center at San Antonio.

An estimated 120,000 Americans are hospitalized annually for severe traumatic brain injuries. Less than 25 percent make a good recovery and many are left with lifelong disabilities and medical needs.

Under the current standard of care, a monitor is inserted into the brain to measure the swelling, or pressure, that occurs within the skull following head trauma. Complications from such pressure, such as bleeding and herniation, can be deadly.

But Jones notes a lack of sufficient oxygen can also be fatal or cause complications due to a loss of brain cells. She said 70 percent to 86 percent of severe brain trauma patients suffer episodes of low oxygen, lasting on average 16 hours.

Doctors who already monitor oxygen intake believe it allows for more timely interventions to increase levels, a hypothesis bolstered by a preliminary study to the new one that hinted at more favorable outcomes in patients monitored for both pressure and oxygen intake.

Jones said previous studies showed no significant risks from drilling the additional hole and the Food and Drug Administration approved the oxygen monitors following studies that demonstrated their safety. She noted the monitors are expensive, so researchers want to make sure they produce better outcomes before recommending routine use.

 

Comments are closed.